Evidence map›Paper›PMID 41462281›Full record

ArticleBMC health services research2025

The impact of COVID-19 social disruptions on general-, mental- and substance use healthcare services among people with and without HIV in the United States.

Jenni M Wise, Jun Y Byun, Lorie Benning, Corilyn Ott, Zenoria Causey Pruitt, Sarah Krier, Daniel Lopez, Janet M Turan, Sheri D Weiser, Gina Wingood and 18 more

Abstract read
In one paragraph

Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Jenni M WiseSchool of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA. jmwise@uab.edu.
Jun Y ByunSchool of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA.
Lorie BenningDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Corilyn OttSchool of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA.
Zenoria Causey PruittSchool of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Sarah KrierSchool of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Daniel LopezSchool of Social Work, Boston University, Boston, MA, USA.
Janet M TuranDepartment of Health Policy and Organization, University of Alabama at Birmingham School of Public Health, Birmingham, AL, USA.
Sheri D WeiserSchool of Medicine, University of California at San Francisco, San Francisco, CA, USA.
Gina WingoodMailman School of Public Health, Columbia University, New York, NY, USA.
Tonya TaylorCollege of Medicine, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
Jennafer KwaitWhitman-Walker Institute, Washington, DC, USA.
Mardge H CohenDepartment of Medicine, Stroger Hospital of Cook County, Chicago, IL, USA.
Brad AouizeratCollege of Dentistry, New York University, New York, NY, USA.
Anjali SharmaDivisions of General Internal Medicine and Infectious Diseases, Albert Einstein College of Medicine, Bronx, NY, USA.
Catalina RamirezSchool of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Matthew J MimiagaDepartment of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA.
Lakshmi GoparajuSchool of Medicine, Georgetown University, Washington, DC, USA.
Anandi N ShethDepartment of Medicine, School of Medicine, Emory University, Atlanta, GA, USA.
Daniel MerensteinSchool of Medicine, Georgetown University, Washington, DC, USA.
Valentina StosorFeinberg School of Medicine, Northwestern University, Evanston, IL, USA.
Adebola AdedimejiDepartment of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Michael PlankeySchool of Medicine, Georgetown University, Washington, DC, USA.
Deborah L JonesDepartment of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Gypsyamber D'SouzaDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Tracey WilsonSchool of Public Health, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
M Reuel FriedmanDepartment of Urban-Global Public Health, School of Public Health, Rutgers University, Newark, NJ, USA.
Mirjam-Colette KempfSchool of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA.

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul A. Goepfert · 1988 to 2026
$84.1M
UAB-MISS MACS/WIHS Combined Cohort StudyU01HL146192 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI James Benjamin Brock, MIRJAM-COLETTE KEMPF · 2019 to 2026
$23.9M
NHLBI NIH HHS U01 HL146192NIAID NIH HHS P30 AI027767
6 · The paper itself

Abstract

backgroundSocial disruptions (e.g., loss of stable housing, employment, income) during the COVID-19 pandemic have been associated with greater mental healthcare and substance use treatment needs in the general population. People with HIV (PWH) may have experienced greater social disruptions during the COVID-19 pandemic due to pre-existing social vulnerabilities and may have experienced greater interruptions in healthcare during the pandemic due to the co-management of chronic and co-morbid conditions, including mental health and substance use disorder diagnoses, which are prevalent among PWH.

methodsBetween April and September 2020, surveys assessing social disruption and healthcare interruption were conducted among Multicenter AIDS Cohort Study/Women’s Interagency HIV Study Combined Cohort Study participants. Descriptive statistics and multivariable logistic regression models were used to characterize and examine the relationships between social disruptions and interruptions in general, mental health, and substance use care, adjusting for sociodemographic characteristics (age, race and ethnicity, region, income, and employment) and HIV status. Qualitative interviews were conducted to add depth and context to quantitative analysis.

resultsAmong 3,665 survey participants (2,238 PWH, 1,427 PWoH), 54% (1214 PWH, 733 PWoH) reported social disruptions and 42% reported healthcare interruptions (972 PWH, 578 PWoH). PWH experiencing ≥ 2 social disruptions had higher odds of missed healthcare appointments (aOR = 1.92, 95%CI:1.56, 2.36) and interrupted mental healthcare (aOR = 2.54, 95%CI:1.83, 3.53) compared to those experiencing < 2. PWoH experiencing ≥ 2 social disruptions had higher odds of missed healthcare appointments, (aOR = 1.65, 95%CI:1.26, 2.17), interrupted mental healthcare (aOR = 2.24, 95%CI:1.38, 3.64), and interrupted substance use treatment (aOR = 2.58, 95%CI:1.15, 5.75) compared to those experiencing < 2. Qualitative interviews elucidated the following reasons for healthcare interruptions: Interruptions in medication and supplies, reduced access to quality healthcare services, self-imposed interruptions related to perceived COVID risk, increased interruptions related to comorbid care needs, reduced access to mental healthcare, and delays in HIV-care.

conclusionHealthcare interruptions during the pandemic inequitably affected vulnerable individuals, especially those experiencing greater social disruptions and those with specialized health care needs. Understanding the impact of pandemic related social disruptions on vulnerable individuals provides an opportunity to address disparities and build a more capable health care system.

Indexed as

COVID-19HIV InfectionsMental DisordersMental Health ServicesSubstance-Related DisordersAdultCohort StudiesFemaleHealth Services AccessibilityHumansMaleMiddle AgedUnited StatesAccessCOVIDHealthcareHIVMWCCSUtilization

Identifiers

PMID41462281
PMCPMC12751715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.